Click for best price
Drugs for Short Bowel Syndrome Market Size, Share 2022
This report contains market size and forecasts of Drugs for Short Bowel Syndrome in Global, including the following market information:
The global Drugs for Short Bowel Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
GLP-2 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs for Short Bowel Syndrome include Ardelyx, Emmaus Life Sciences, GLyPharma Therapeutic, Merck, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio & Company and Takeda and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Short Bowel Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Short Bowel Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Short Bowel Syndrome Market Segment Percentages, by Type, 2021 (%)
- GLP-2
- Growth Hormone
- Glutamine
- Other
Global Drugs for Short Bowel Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Short Bowel Syndrome Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Drugs for Short Bowel Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drugs for Short Bowel Syndrome Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Drugs for Short Bowel Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Drugs for Short Bowel Syndrome revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Ardelyx
- Emmaus Life Sciences
- GLyPharma Therapeutic
- Merck
- Naia Pharmaceuticals
- Nutrinia
- OxThera
- Sancilio & Company
- Takeda
- Zealand Pharma
| Report Attributes |
Report Details |
| Report Title |
Drugs for Short Bowel Syndrome Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Short Bowel Syndrome Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Short Bowel Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Short Bowel Syndrome Overall Market Size
2.1 Global Drugs for Short Bowel Syndrome Market Size: 2021 VS 2028
2.2 Global Drugs for Short Bowel Syndrome Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Short Bowel Syndrome Players in Global Market
3.2 Top Global Drugs for Short Bowel Syndrome Companies Ranked by Revenue
3.3 Global Drugs for Short Bowel Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Short Bowel Syndrome Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drugs for Short Bowel Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Short Bowel Syndrome Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drugs for Short Bowel Syndrome Market Size Markets, 2021 & 2028
4.1.2 GLP-2
4.1.3 Growth Hormone
4.1.4 Glutamine
4.1.5 Other
4.2 By Type - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
4.2.1 By Type - Global Drugs for Short Bowel Syndrome Revenue, 2017-2022
4.2.2 By Type - Global Drugs for Short Bowel Syndrome Revenue, 2023-2028
4.2.3 By Type - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Short Bowel Syndrome Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
5.2.1 By Application - Global Drugs for Short Bowel Syndrome Revenue, 2017-2022
5.2.2 By Application - Global Drugs for Short Bowel Syndrome Revenue, 2023-2028
5.2.3 By Application - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Drugs for Short Bowel Syndrome Market Size, 2021 & 2028
6.2 By Region - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
6.2.1 By Region - Global Drugs for Short Bowel Syndrome Revenue, 2017-2022
6.2.2 By Region - Global Drugs for Short Bowel Syndrome Revenue, 2023-2028
6.2.3 By Region - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Drugs for Short Bowel Syndrome Revenue, 2017-2028
6.3.2 US Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.3.3 Canada Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.3.4 Mexico Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Drugs for Short Bowel Syndrome Revenue, 2017-2028
6.4.2 Germany Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.3 France Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.4 U.K. Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.5 Italy Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.6 Russia Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.7 Nordic Countries Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.8 Benelux Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Drugs for Short Bowel Syndrome Revenue, 2017-2028
6.5.2 China Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.5.3 Japan Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.5.4 South Korea Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.5.5 Southeast Asia Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.5.6 India Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Drugs for Short Bowel Syndrome Revenue, 2017-2028
6.6.2 Brazil Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.6.3 Argentina Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue, 2017-2028
6.7.2 Turkey Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.7.3 Israel Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.7.4 Saudi Arabia Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.7.5 UAE Drugs for Short Bowel Syndrome Market Size, 2017-2028
7 Players Profiles
7.1 Ardelyx
7.1.1 Ardelyx Corporate Summary
7.1.2 Ardelyx Business Overview
7.1.3 Ardelyx Drugs for Short Bowel Syndrome Major Product Offerings
7.1.4 Ardelyx Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.1.5 Ardelyx Key News
7.2 Emmaus Life Sciences
7.2.1 Emmaus Life Sciences Corporate Summary
7.2.2 Emmaus Life Sciences Business Overview
7.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Major Product Offerings
7.2.4 Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.2.5 Emmaus Life Sciences Key News
7.3 GLyPharma Therapeutic
7.3.1 GLyPharma Therapeutic Corporate Summary
7.3.2 GLyPharma Therapeutic Business Overview
7.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Major Product Offerings
7.3.4 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.3.5 GLyPharma Therapeutic Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Drugs for Short Bowel Syndrome Major Product Offerings
7.4.4 Merck Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.4.5 Merck Key News
7.5 Naia Pharmaceuticals
7.5.1 Naia Pharmaceuticals Corporate Summary
7.5.2 Naia Pharmaceuticals Business Overview
7.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Major Product Offerings
7.5.4 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.5.5 Naia Pharmaceuticals Key News
7.6 Nutrinia
7.6.1 Nutrinia Corporate Summary
7.6.2 Nutrinia Business Overview
7.6.3 Nutrinia Drugs for Short Bowel Syndrome Major Product Offerings
7.6.4 Nutrinia Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.6.5 Nutrinia Key News
7.7 OxThera
7.7.1 OxThera Corporate Summary
7.7.2 OxThera Business Overview
7.7.3 OxThera Drugs for Short Bowel Syndrome Major Product Offerings
7.7.4 OxThera Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.7.5 OxThera Key News
7.8 Sancilio & Company
7.8.1 Sancilio & Company Corporate Summary
7.8.2 Sancilio & Company Business Overview
7.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Major Product Offerings
7.8.4 Sancilio & Company Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.8.5 Sancilio & Company Key News
7.9 Takeda
7.9.1 Takeda Corporate Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Drugs for Short Bowel Syndrome Major Product Offerings
7.9.4 Takeda Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.9.5 Takeda Key News
7.10 Zealand Pharma
7.10.1 Zealand Pharma Corporate Summary
7.10.2 Zealand Pharma Business Overview
7.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Major Product Offerings
7.10.4 Zealand Pharma Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.10.5 Zealand Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs for Short Bowel Syndrome Market Opportunities & Trends in Global Market
Table 2. Drugs for Short Bowel Syndrome Market Drivers in Global Market
Table 3. Drugs for Short Bowel Syndrome Market Restraints in Global Market
Table 4. Key Players of Drugs for Short Bowel Syndrome in Global Market
Table 5. Top Drugs for Short Bowel Syndrome Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Drugs for Short Bowel Syndrome Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Drugs for Short Bowel Syndrome Revenue Share by Companies, 2017-2022
Table 8. Global Companies Drugs for Short Bowel Syndrome Product Type
Table 9. List of Global Tier 1 Drugs for Short Bowel Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Drugs for Short Bowel Syndrome Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Drugs for Short Bowel Syndrome Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2023-2028
Table 30. Ardelyx Corporate Summary
Table 31. Ardelyx Drugs for Short Bowel Syndrome Product Offerings
Table 32. Ardelyx Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 33. Emmaus Life Sciences Corporate Summary
Table 34. Emmaus Life Sciences Drugs for Short Bowel Syndrome Product Offerings
Table 35. Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 36. GLyPharma Therapeutic Corporate Summary
Table 37. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product Offerings
Table 38. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Drugs for Short Bowel Syndrome Product Offerings
Table 41. Merck Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 42. Naia Pharmaceuticals Corporate Summary
Table 43. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product Offerings
Table 44. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 45. Nutrinia Corporate Summary
Table 46. Nutrinia Drugs for Short Bowel Syndrome Product Offerings
Table 47. Nutrinia Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 48. OxThera Corporate Summary
Table 49. OxThera Drugs for Short Bowel Syndrome Product Offerings
Table 50. OxThera Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 51. Sancilio & Company Corporate Summary
Table 52. Sancilio & Company Drugs for Short Bowel Syndrome Product Offerings
Table 53. Sancilio & Company Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 54. Takeda Corporate Summary
Table 55. Takeda Drugs for Short Bowel Syndrome Product Offerings
Table 56. Takeda Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 57. Zealand Pharma Corporate Summary
Table 58. Zealand Pharma Drugs for Short Bowel Syndrome Product Offerings
Table 59. Zealand Pharma Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Drugs for Short Bowel Syndrome Segment by Type in 2021
Figure 2. Drugs for Short Bowel Syndrome Segment by Application in 2021
Figure 3. Global Drugs for Short Bowel Syndrome Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Drugs for Short Bowel Syndrome Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drugs for Short Bowel Syndrome Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Short Bowel Syndrome Revenue in 2021
Figure 8. By Type - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 9. By Application - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 10. By Region - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 11. By Country - North America Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 12. US Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 16. Germany Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 17. France Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 24. China Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 28. India Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 30. Brazil Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 33. Turkey Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 37. Ardelyx Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Nutrinia Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. OxThera Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sancilio & Company Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Takeda Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zealand Pharma Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
